4.7 Article

Structural basis of Keap1 interactions with Nrf2

期刊

FREE RADICAL BIOLOGY AND MEDICINE
卷 88, 期 -, 页码 101-107

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2015.05.034

关键词

Keap1; Nrf2; BTB; Kelch; Cullin; Ubiquitin; Free radicals

资金

  1. AbbVie [1097737]
  2. Bayer
  3. Boehringer Ingelheim
  4. Genome Canada through Ontario Genomics Institute Grant [OGI-055]
  5. GlaxoSmithKline
  6. Janssen
  7. Lilly Canada
  8. Novartis Research Foundation
  9. Ontario Ministry of Economic Development and Innovation
  10. Pfizer
  11. Takeda
  12. Wellcome Trust Grant [092809/Z/10/Z]
  13. Wellcome Trust [092809/Z/10/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

Keap1 is a highly redox-sensitive member of the BTB-Kelch family that assembles with the Cul3 protein to form a Cullin-RING E3 ligase complex for the degradation of Nrf2. Oxidative stress disables Keap1, allowing Nrf2 protein levels to accumulate for the transactivation of critical stress response genes. Consequently, the Keap1-Nrf2 system is extensively pursued for the development of protein-protein interaction inhibitors that will stabilize Nrf2 for therapeutic effect in conditions of neurodegeneration, inflammation, and cancer. Here we review current progress toward the structure determination of Keap1 and its protein complexes with Cul3, Nrf2 substrate, and small-molecule antagonists. Together the available structures establish a rational three-dimensional model to explain the two-site binding of Nrf2 as well as its efficient ubiquitination. (C) 2015 The Authors. Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据